improving global access to novel immunotherapies for patients with r/r dlbcl
Published 2 months ago • 99 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:55
improving global accessibility of myeloma treatment
-
0:57
novel therapeutic strategies in all
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
1:08
novel immunotherapies for multiple myeloma & other exciting developments
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
1:02
the challenge of treating bpdcn in a resource-limited setting
-
2:26
strategies to improve the efficacy of immunotherapy in indolent b-cell lymphomas
-
1:15
bringing novel agents to the frontline setting in myeloma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents